Vibeke Strand, MD, FACP, FACR

Vibeke Strand, MD, FACP, FACR, is Adjunct Clinical Professor in the Division of Immunology and Rheumatology at Stanford University School of Medicine and a consultant in clinical research and regulatory affairs to pharmaceutical and biotech companies. She has been a clinical rheumatologist for 25 years. Her professional interests include development of clinical trial methodology, planning regulatory strategy and clinical studies leading to approval of new agents for treatment of autoimmune diseases, including rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Her focus is to help translate basic research into clinical trials, evaluate results of these randomized controlled trials and defend successful clinical development at FDA. Her commitment to promoting forums for the discussion of rational product development among industry, FDA and academia led to her establishment and co-chairing of the biyearly "Innovative Therapies in Autoimmune Disease" meetings (1988-2005), organizing committee membership of the international Outcomes in Rheumatology Clinical Trials (OMERACT 1-7) consensus conferences (1992-2004), and co-chairing of OMERACT 7 in 2004. She has been an invited speaker at FDA Arthritis Advisory Committee meetings discussing Guidance Documents for RA, OA, SLE, JRA, radiographic analyses in RA and pain (1996 - 2003). She has authored over 100 articles, 25 chapters, co-edited several books and multiple proceedings. She is a Fellow of the American College of Physicians (1982), a Fellow of the American College of Rheumatology (1986), serves on the editorial board of several rheumatology journals, and is a member of the Cosmos Club (1994).